about
Development of diaminoquinazoline histone lysine methyltransferase inhibitors as potent blood-stage antimalarial compoundsApicoplast isoprenoid precursor synthesis and the molecular basis of fosmidomycin resistance in Toxoplasma gondii.2-Substituted 4,5-dihydrothiazole-4-carboxylic acids are novel inhibitors of metallo-β-lactamasesCurrent advances in antifungal targets and drug development.Coordination chemistry based approach to lipophilic inhibitors of 1-deoxy-D-xylulose-5-phosphate reductoisomerase.Identification of 2,4-diamino-6,7-dimethoxyquinoline derivatives as G9a inhibitors†Electronic supplementary information (ESI) available. See DOI: 10.1039/c4md00274a.Conformational polymorphism in sulfonylurea drugs: electronic structure analysis.New antimicrobial hexapeptides: synthesis, antimicrobial activities, cytotoxicity, and mechanistic studies.On the histone lysine methyltransferase activity of fungal metabolite chaetocin.New PPARgamma ligands based on barbituric acid: virtual screening, synthesis and receptor binding studies.New PPARgamma ligands based on 2-hydroxy-1,4-naphthoquinone: computer-aided design, synthesis, and receptor-binding studies.Histone lysine methyltransferase structure activity relationships that allow for segregation of G9a inhibition and anti-Plasmodium activity.Thienopyrimidinone Based Sirtuin-2 (SIRT2)-Selective Inhibitors Bind in the Ligand Induced Selectivity Pocket.Important pharmacophoric features of pan PPAR agonists: common chemical feature analysis and virtual screening.'Sum of activities' as dependent parameter: a new CoMFA-based approach for the design of pan PPAR agonists.Minimum requirements of hydrophobic and hydrophilic features in cationic peptide antibiotics (CPAs): pharmacophore generation and validation with cationic steroid antibiotics (CSAs).Apicoplast isoprenoid precursor synthesis and the molecular basis of fosmidomycin resistance inToxoplasma gondiiMolecular electrostatic potentials in the design of dendrimers for the delivery of glitazonesIdentification of antimalarial leads with dual falcipain-2 and falcipain-3 inhibitory activity
P50
Q34254755-6228F671-EF75-4909-AC5E-78459E0E0A2DQ35102319-571F84CE-63D1-4573-9CC7-BA2CABA8C0ACQ36294078-DC4B76DC-BA1D-4645-91CD-7F6DF218EE81Q36483030-2C32814A-CDEA-4DF0-A64A-55E88E97FB36Q39779186-E7D3A977-01D4-4A3A-AE54-E0BB07910E99Q41269425-DD2CD127-CFDC-4947-8C1F-3D88D157C15DQ42934227-BC3545C6-6180-43DF-B145-56FA2EC068DFQ43234704-3F0E44ED-516F-43A1-8B61-845F8D83B693Q44583947-4DBE98E4-2392-4CAC-998C-4069F0938582Q46407532-B27D3BCA-1DAB-4789-B8F8-4576386EDD7FQ46593678-B3146EC8-D5AD-4478-BDD1-841E84E225F8Q47200073-20FDAB0F-DF69-4204-AB46-4846C3FEF771Q48298219-BBE2A4E1-1AC1-48A0-B248-03DF2FFD3DBEQ51779517-8B92BE57-7F45-4A71-8130-806A794D2DBAQ51887425-75D1407A-B4FF-470B-87A6-FD6F02717886Q54426552-7E892E42-EB77-462E-98A0-0EFAE2193356Q63363557-6CB5F5C6-820B-4685-A711-A460AD5F23B2Q79265505-F643EBB2-C5DE-483C-82A2-D06B8074B2F0Q91343414-075FF333-8F2D-4BC3-A757-EA3904D05217
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Sandeep Sundriyal
@ast
Sandeep Sundriyal
@en
Sandeep Sundriyal
@es
Sandeep Sundriyal
@nl
Sandeep Sundriyal
@sl
type
label
Sandeep Sundriyal
@ast
Sandeep Sundriyal
@en
Sandeep Sundriyal
@es
Sandeep Sundriyal
@nl
Sandeep Sundriyal
@sl
prefLabel
Sandeep Sundriyal
@ast
Sandeep Sundriyal
@en
Sandeep Sundriyal
@es
Sandeep Sundriyal
@nl
Sandeep Sundriyal
@sl
P106
P1153
23494285600
P21
P31
P496
0000-0001-7823-8842
P569
2000-01-01T00:00:00Z